News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
449,401 Results
Type
Article (24503)
Company Profile (158)
Press Release (424740)
Section
Business (124805)
Career Advice (450)
Deals (20477)
Drug Delivery (38)
Drug Development (79084)
Employer Resources (45)
FDA (12542)
Job Trends (9327)
News (234261)
Policy (18795)
Tag
Academia (1716)
Alliances (33621)
Alzheimer's disease (1241)
Approvals (12492)
Artificial intelligence (136)
Bankruptcy (144)
Best Places to Work (8159)
Biotechnology (120)
Breast cancer (180)
Cancer (1331)
Cardiovascular disease (100)
Career advice (391)
CAR-T (97)
Cell therapy (265)
Clinical research (64547)
Collaboration (417)
Compensation (203)
COVID-19 (2023)
C-suite (95)
Data (1369)
Diabetes (145)
Diagnostics (4949)
Earnings (46500)
Events (71713)
Executive appointments (327)
FDA (13158)
Funding (371)
Gene therapy (168)
GLP-1 (451)
Government (2270)
Healthcare (13765)
Infectious disease (2095)
Inflammatory bowel disease (113)
IPO (10823)
Job creations (1516)
Job search strategy (356)
Layoffs (259)
Legal (2353)
Lung cancer (196)
Lymphoma (93)
Manufacturing (133)
Medical device (9155)
Medtech (9155)
Mergers & acquisitions (9877)
Metabolic disorders (358)
Neuroscience (1549)
NextGen Class of 2024 (3921)
Non-profit (2480)
Northern California (1522)
Obesity (182)
Opinion (126)
Parkinson's disease (94)
Patents (80)
People (37580)
Phase I (20761)
Phase II (28786)
Phase III (20842)
Pipeline (478)
Postmarket research (2059)
Preclinical (7443)
Radiopharmaceuticals (235)
Rare diseases (235)
Real estate (2916)
Regulatory (15379)
Research institute (1845)
Southern California (1308)
Startups (2412)
United States (12508)
Vaccines (396)
Weight loss (103)
Date
Today (6)
Last 7 days (81)
Last 30 days (1767)
Last 365 days (29299)
2025 (6)
2024 (29391)
2023 (33261)
2022 (41156)
2021 (43153)
2020 (39757)
2019 (30862)
2018 (23245)
2017 (23949)
2016 (21948)
2015 (25647)
2014 (18528)
2013 (13926)
2012 (14584)
2011 (14975)
2010 (14088)
Location
Africa (368)
Arizona (90)
Asia (27337)
Australia (5362)
California (3350)
Canada (1126)
China (280)
Colorado (148)
Connecticut (152)
Europe (62322)
Florida (425)
Georgia (110)
Illinois (238)
Indiana (168)
Japan (78)
Maryland (462)
Massachusetts (2531)
Michigan (105)
Minnesota (180)
New Jersey (897)
New York (918)
North Carolina (632)
Northern California (1522)
Ohio (105)
Pennsylvania (777)
South America (488)
Southern California (1308)
Texas (505)
Utah (88)
Washington State (339)
449,401 Results for "george clinical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Nkarta Adds Experienced Leader in Autoimmune R&D, George Vratsanos, M.D., FACR, to Board of Directors
Nkarta, Inc., a clinical-stage biopharmaceutical company developing engineered natural killer cell therapies announced that translational immunology expert George Vratsanos, M.D., FACR, is joining its board of directors.
June 13, 2024
·
5 min read
Business
Calidi Biotherapeutics Announces Appointment of Cancer Immunotherapy Pioneer Dr. George Peoples to Board of Directors
Calidi Biotherapeutics, Inc. today announced the appointment of Dr. George E. Peoples, MD, FACS, to the company’s Board of Directors, effective July 1, 2024.
June 27, 2024
·
4 min read
Business
Mythic Therapeutics Appoints George Eliades, Ph.D., as President and Chief Executive Officer
Mythic Therapeutics, a clinical-stage biotechnology company committed to the development of next-generation antibody-drug conjugate (ADC) therapies for the treatment of a wide range of cancers, announced that George Eliades, Ph.D., has joined the company as President and Chief Executive Officer (CEO).
March 28, 2024
·
2 min read
Business
George Medicines Appoints Mark Mallon as Chief Executive Officer and Board Director
George Medicines announces the appointment of Mark Mallon as its new Chief Executive Officer and Board Director, effective immediately.
April 29, 2024
·
3 min read
Business
Myriad Genetics Names George Daneker Jr., MD, as President and Chief Clinical Officer of Oncology
Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the appointment of George Daneker Jr., MD, as President and Chief Clinical Officer of Oncology, effective March 18, 2024.
January 30, 2024
·
3 min read
Series B
George Church Startup Nets $60M to Take Non-Standard Amino Acids to the Clinic
GRO Biosciences will use the Series B funds to launch a Phase I trial for ProGly-Uricase, its investigational therapy for gout.
July 19, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Neurosurgeon Joseph Georges, P.I. for Diakonos Oncology’s Phase 1 Trial of Its Unique Dendritic Cell Vaccine for Gliobastoma, Receives the CNS 2024 Rosenblum-Mahaley Clinical Research Award
October 15, 2024
·
3 min read
Drug Development
ZyVersa Therapeutics Engages CRO, George Clinical, for Phase 2a Clinical Trial for Cholesterol Efflux Mediator VAR 200
ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA; “ZyVersa”) announces selection of contract research organization (“CRO”) George Clinical to manage its Phase 2a clinical trial with Cholesterol Efflux MediatorTM VAR 200 in patients with diabetic kidney disease (DKD).
December 14, 2023
·
6 min read
Press Releases
Potential of George Medicines’ novel, low-dose, triple combination pill to transform management of hypertension highlighted at global congress
September 25, 2024
·
6 min read
Business
Corsair Pharma Announces Appointment of George W. Mahaffey as Chief Executive Officer
Corsair Pharma, Inc. today announced the appointment of George W. Mahaffey as Chief Executive Officer.
December 11, 2023
·
3 min read
1 of 44,941
Next
